ChronTech Pharma AB Report issue

For profit Phase 2
Founded: Huddinge Sweden (1997)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2007
NCT00563173
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Tripep AB

Active Ingredients

Drugs in Phase 2 Trials (1)

chronvac-c (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1